| 08:00 – 10:00 | WICH Executive Board meeting (per invitation only) |
| 10:00 – 10:30 | Morning break |
| 10:30 – 12:00 | Advancing Clinical Trials (per invitation only) Chairs: Craig Anderson & Magdy Selim INTERACT5, Lili Song & Xin (Eric) Hu International cooperation and funding – ACT Global, Xiaoying Chen StrokeNet perspectives, Magdy Selim Prospective meta-analysis and data sharing, Xia Wang, Niki Sprigg Registries, David Seiffge |
| 12:00 – 13:00 | Lunch |
| 13:00 – 15:15 | HEADS Meeting EVERY MINUTE COUNTS: A PARADIGM SHIFT IN ICH (per invitation only) Session I Welcome / introductions Chairs: Chao You, Kazunori Toyoda Detection of ICH in the field (GFAP and imaging), Love-Preet Kalra, Geoffrey Donnan Approaches to surgical evacuation, Jay Mocco, Amal Abou-Hamden, Xing (Eric) Hu, Andrew Mould Reversal of coagulopathy, Ashkan Shoamanesh, David Seiffge |
| 15:15 – 15:30 | Afternoon break |
| 15:30 – 17:00 | HEADS Meeting EVERY MINUTE COUNTS: A PARADIGM SHIFT IN ICH (per invitation only) Session II Chairs: Karin Klijn, Xin Chen Approaches to BP lowering, Lili Song, Craig Anderson Reorganizing ICH systems of care and use of AI, Teresa Ullberg, Carlos Molina |
| 17:00 – 18:30 | Break |
| 19:00 | HEADS DINNER (per invitation only) |
| 08:30 – 08:45 | OPENING CEREMONY AND WELCOME TO COUNTRY Chairs: Craig Anderson & Magdy Selim |
| 08:45 – 10:30 | SESSION I – WHERE NEXT FOR MEDICAL TREATMENT? Chairs: David Rodríguez, Chao You |
| 08:45 – 09:10 | Haemostatic therapy, Niki Sprigg |
| 09:10 – 09:30 | Blood pressure lowering treatment, Xia Wang, Lili Song |
| 09:30 – 09:45 | Expert discussants, Kazunori Toyoda, Timothy Kleinig, Adnan Qureshi |
| 09:45 – 10:00 | Audience discussion |
| 10:00 – 10:30 | Oral Presentations Optimal Magnitude of Blood Pressure Reduction and Hematoma Growth and Functional Outcomes in ICH, Qi Li, China Stable SBP Reduction as a Therapeutic Goal in ICH: Pooled Analysis of ATACH-2 and INTERACT-2 Trials, Adnan I. Qureshi, US Remote Ischemic Conditioning for Patients With Supratentorial Intracerebral Hemorrhage (RICH-2), Wenbo Zhao, China |
| 10:30 – 11:00 | Morning break |
| 11:00 – 12:30 | SESSION II – BASIC SCIENCE, PATHOPHYSIOLOGY, NOVEL THERAPIES Chairs: Richard Keep, Adrian Parry-Jones |
| 11:00 – 11:20 | Expert Overview, Richard Keep |
| 11:20 – 11:40 | Expert discussant, Adrian Parry-Jones, Niki Sprigg |
| 11:40 – 12:00 | Audience discussion |
| 12:00 – 12:30 | Discussion |
| 12:30 – 13:30 | Lunch |
| 12:45 – 13:30 | MODERATED POSTER SESSION I |
| INTERACTIVE TRAINING WORKSHOPS | |
| 13:30 – 15:00 | SESSION III – APPROACHES TO SURGICAL TREATMENT Chairs: Xunming Ji, Gao Chen, Jay Mocco |
| 13:30 – 13:45 | Minimally invasive surgery in China, Zhenchun Liu, Xia Wang |
| 13:45 – 14:00 | Minimally invasive surgery outside China, Karin Klijn |
| 14:00 – 14:10 | Minimally invasive surgery in Australia, Amal Abou-Hamden |
| 14:10 – 14:30 | Discussion |
| 14:30 – 15:00 | Oral Presentations Association Between Hematoma Evacuation and Ischemic Events: A MISTIE III and ATACH-2 Analysis, Wendy Ziai, US Minimally Invasive Surgery for Deep and Lobar Intracranial Hemorrhages: 180-day MIND Study Results, Christopher Kellner, US Comparison of Minimally Invasive Surgery Treatments for Hypertension Intracerebral Hemorrhage, Yuanwei Li, China |
| 15:00 – 15:30 | Afternoon break |
| 15:30 – 17:00 | SESSION V – DIRECTIONS FOR PRE-HOSPITAL MANAGEMENT Chairs: Thorstein Steiner, Carlos Molina |
| 15:30 – 15:45 | GFAP and clinical prediction, Cheryl Carcel |
| 15:45 – 16:00 | Novel imaging and devices, Geoffrey Donnan |
| 16:00 – 16:15 | Ambulance pathways and management, David Paterson |
| 16:15 – 16:30 | Discussion |
| 16:30 – 17:00 | Oral Presentations Pre-hospital Blood Pressure Variability in Intracerebral Hemorrhage on a Mobile Stroke Unit, Chloe Mutimer, Australia Impact of Direct Transfer of ICH to the Angiosuite on BP and Anticoagulation Reversal Time Metrics, David Rodriguez-Luna, Spain |
| 17:00 | Finish |
| 18:30 – 21:30 | WELCOME RECEPTION |
| 10:30 – 11:00 | Morning break |
| 12:30 – 13:30 | Lunch |
| 12:45 – 13:30 | MODERATED POSTER SESSION I |
| 13:30 – 15:00 |
SESSION IV – ISSUES OF REHABILITATION AND RECOVERY Chairs: PN Sylaja, Stephen Faux |
| 13:30 – 13:45 | Early mobilisation, Emily Ramage |
| 13:45 – 14:00 | Cognition and dementia, Hsin-Hsi (Cynthia) Tsai |
| 14:00 – 14:10 | Management of complications, Stephen Faux |
| 14:10 – 14:30 | Discussion |
| 14:30 – 15:00 |
Oral Presentations: – Intracerebral hemorrhage intelligent staging based on a symptom-time extracted large language model, Xiaochao Luo, China – Quality of Functional Outcome and its determinants in ICH. Insights from the INTERACT3 trial, Carlos Delfino, Chile – Time-Dependent Association of SBP Fluctuations with Outcomes in ICH: Post Hoc ATACH-2 Analysis, Adnan I. Qureshi, US |
| 15:00 – 15:30 | Afternoon break |
| 15:30 – 17:00 |
SESSION VI – TRENDS IN EPIDEMIOLOGY AND OUTCOMES Chairs: Octavio Pontes Neto, PN Sylaja |
| 15:30 – 15:45 | Burden of disease – Vasileios-Arsenois Lioutas |
| 15:45 – 16:00 | Recovery patterns – Octavio Pontes Neto |
| 16:00 – 16:15 | Management in low-resource settings – PN Sylaja |
| 16:15 – 16:30 | Discussion |
| 16:30 – 17:00 |
Oral Presentations: – Burden of Stroke and Risk Factors in China: an Analysis of the Global Burden of Disease Study 2021, Siyu Yan, China – Impact of socioeconomic status on functional outcome after stroke in Ulaanbaatar, Mongolia, Yijie Gao, Australia |
| 17:00 | Finish |
| 18:30 – 21:30 | WELCOME RECEPTION |
| 08:30 – 09:00 | THE JULIAN T HOFF AWARD & AWARDS |
| 09:00 – 10:30 | SESSION VII – MANAGEMENT OF ANTICOAGULATION-RELATED CEREBRAL HAEMORRHAGE Chairs: Adnan Qureshi, Andrea Morotti |
| 09:00 – 09:20 | Expert Overview , David Seiffge |
| 09:20 – 09:40 | Expert discussants, Ashkan Shoamanesh, Andrea Morotti |
| 09:40 – 10:00 | Audience discussion |
| 10:00 – 10:10 | ICH ADAPT II trial, Ken Butcher |
| 10:10 – 10:30 | Oral Presentations Early Intensive Blood Pressure Control in Intracerebral Hemorrhage during Antithrombotic Use, Menglu Ouyang, Australia Translation of Cellular Phenotypic Changes from In-Vitro ICH Model to In-Vivo Mouse and Human Brain, Thomas Kent, US |
| 10:30 – 11:00 | Morning break |
| 11:00 – 12:30 | SESSION VIII – CARE BUNDLE PROTOCOLS AND NURSING CARE Chairs: Thorstein Steiner, Trine Apostolaki-Hansson |
| 11:00 – 11:20 | Expert Overview, Teresa Ullberg |
| 11:20 – 11:40 | Expert discussants, Menglu Ouyang, Adrian Parry-Jones |
| 11:40 – 12:00 | Audience discussion |
| 12:00 – 12:30 | Oral Presentations Ethnic Disparities in Early Do-Not-Attempt-Resuscitation Orders Following ICH: A Prospective Study, Zhe Kang Law, Malaysia Systolic blood pressure trajectory and outcomes in acute intracerebral haemorrhage, Xia Wang, Australia |
| 12:30 – 13:30 | Lunch |
| 12:45 – 13:30 | MODERATED POSTER SESSION I |
| 13:30 – 15:00 | SESSION IX – DEVELOPMENTS IN MANAGEMENT OF SAH, AVM AND STRUCTURAL CAUSES OF BRAIN HEMORRHAGE Chairs: Jay Mocco, You Chao |
| 13:30 – 13:50 | Management of SAH, Amal Abou-Hamden |
| 13:50 – 14:10 | Management of cavernomas, Wei Zhu |
| 14:10 – 14:40 | Management of AVMs, Marcus Stoodley |
| 14:40 – 15:00 | Oral Presentations Correlation between complement activation and early brain injury in human subarachnoid hemorrhage., Richard Keep, US Seizure prophylaxis in aneurysmal subarachnoid hemorrhage across China, Manni Wang, China |
| 15:00 – 15:30 | Afternoon break |
| 15:30 – 17:00 | SESSION XI– SECONDARY PREVENTION Chairs: Xiaoying Chen, Sheila Martins |
| 15:30 – 15:50 | Blood pressure control, Anthony Rodgers |
| 15:50 – 16:10 | Antithrombotic treatment, Xin Cheng |
| 16:10 – 16:30 | Combination strategies, Sheila Martins |
| 16:30 – 17:00 | Oral Presentations Update on the Triple therapy prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT), Natalie Espinosa, AustraliaInterim Result of MOBILE Health Intervention after IntraCerebral Hemorrhage, Kay Cheong Teo, Hong Kong |
| 17:00 | Finish |
| 19:00 – 22:00 | GALA DINNER |
| 10:30 – 11:00 | Morning break |
| 12:30 – 13:30 | Lunch |
| 12:45 – 13:30 | MODERATED POSTER SESSION I |
| 13:30 – 15:00 | SESSION X – DIAGNOSIS AND TREATMENT OF CEREBRAL SMALL VESSEL DISEASE AND CEREBRAL AMYLOID ANGIOPATHY Chairs: Hsin-Hsi (Cynthia) Tsai, Floris Schreuder |
| 13:30 – 13:50 | Diagnosis, Floris Schreuder |
| 13:50 – 14:10 | Advancing medical management, Hsin-Hsi (Cynthia) Tsai |
| 14:10 – 14:40 | Outcome prediction, Xin Cheng |
| 14:40 – 15:00 | Oral Presentations The probability of cerebral amyloid angiopathy in lobar intracerebral hemorrhage on head CT, Amir Hillal, Sweden CN-105 in Acute Supratentorial ICH Trial: A Phase 2b, Randomised Controlled Trial, Tien Meng Cheong, Singapore |
| 15:00 – 15:30 | Afternoon break |
| 15:30 – 17:00 | SESSION XII – PROGNOSTIC ALGORITHMS Chairs: Wendy Ziai, Xia Wang |
| 15:30 – 15:50 | Imaging markers, Bernard Yan |
| 15:50 – 16:10 | NeuroICU care, Wendy Ziai |
| 16:10 – 16:30 | Defining patient responder groups, Andrea Morotti |
| 16:30 – 17:00 | Oral Presentations The association between location-specific pre-scan hematoma growth and hematoma expansion, Kay Cheong Teo, Hong KongAre hematoma Hounsfield Units a quantitative marker of growth in intracerebral hemorrhage?, Chloe Mutimer, Australia |
| 17:00 | Finish |
| 19:00 – 22:00 | GALA DINNER |